Recursion Pharmaceuticals (MEX:RXRX) Net Interest Margin (Bank Only) %


MEX:RXRX Recursion Pharmaceuticals Inc MEX:RXRX
57 GF Score
Price MXN62.20
GF Value MXN73.63
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Recursion Pharmaceuticals Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

MEX:RXRX
57GF Score
Recursion Pharmaceuticals Inc MEX:RXRX
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Recursion Pharmaceuticals (MEX:RXRX) Overvalued in 2026?

Based on GuruFocus' analysis, Recursion Pharmaceuticals stock appears to be undervalued. The current stock price of MXN62.20 is trading 15.5% below its estimated GF Value™ of MXN73.63. GuruFocus considers Recursion Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for MEX:RXRX:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: MXN73.63 vs. price of MXN62.20 (15.5% below fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the MEX:RXRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Recursion Pharmaceuticals Business Description

Other Exchanges RXRX:USA
Address 41 South Rio Grande Street, Salt Lake City, UT, USA, 84101
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
57GF Score

Get the complete analysis for MEX:RXRX

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN62.20
Price
MXN73.63
GF Value